| Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231) |
|---|
| 09/15/2005 | US20050202473 Using variation in nucleotide repeat sequences as diagnostic indicators of cell proliferative disorders |
| 09/15/2005 | US20050202472 Using long transient receptor potential channels (LTRPC2) as tools in identifying modulators for intracellular calcium concentration |
| 09/15/2005 | US20050202471 Integrated microfluidic disc |
| 09/15/2005 | US20050202470 Binding assays using molecular melt curves |
| 09/15/2005 | US20050202469 Multiplexed analysis of clinical specimens apparatus and methods |
| 09/15/2005 | US20050202468 Nucleic acid sequencing by Raman monitoring of uptake of nucleotides during molecular replication |
| 09/15/2005 | US20050202467 Nucleotide sequences coding serotonin receptor (5-HT1A receptor) for use in identifying modulators for prevntion and treatment of neuropsychiatric disorders |
| 09/15/2005 | US20050202466 Method for sequencing nucleic acid molecules |
| 09/15/2005 | US20050202465 Using hyperdiploid state of thymidylate synthase gene as tool in diagnosis/prognosis of cell proliferative disorders |
| 09/15/2005 | US20050202464 Radiative decay engineering |
| 09/15/2005 | US20050202463 Modulators of dimethylarginine dimethylaminohydrolase and methods of use thereof |
| 09/15/2005 | US20050202461 Using sequence specific primers to amplify RNA sequence; preparing cDNA library |
| 09/15/2005 | US20050202460 Methods and compositions for detecting Bacillus species |
| 09/15/2005 | US20050202459 Non-natural polynucleotide formed via fluid comprising template and intercalator, and ligating |
| 09/15/2005 | US20050202458 Using serial analysis of gene expression (SAGE) to identify tumor specific genes; immuotherapy; tissue targeted therapy |
| 09/15/2005 | US20050202457 Preparing microarray comprising cell surface ligands for use as to in separation and classification of cell types |
| 09/15/2005 | US20050202456 Processes for detecting or quantifying analytes of interest |
| 09/15/2005 | US20050202455 Process for producing two or more copies of nucleic acids in a library, and process for detecting or quantifiying more than one nucleic acid in a library |
| 09/15/2005 | US20050202454 "STRAP" and "STEAP"(six transmembrane (epithelial) antigen of the prostate) |
| 09/15/2005 | US20050202453 Using rolling circle amplification (RCA) to replicate plasmid DNA, isolated from yeast , comprising heterologous gene sequences; gene expression analysis; DNA sequencing; yeast two-hybrid analysis |
| 09/15/2005 | US20050202452 Assay determining the activity of an agent to decrease cell division; contacting protein capable of superoxide production with compound of interest and and measuring the ability of the agent to decrease superoxide production, inhibit diaphorase activity or bind the protein |
| 09/15/2005 | US20050202451 Methods and apparatuses for diagnosing AML and MDS |
| 09/15/2005 | US20050202450 Polypeptides stable under hypoxic and nonhypoxic conditions; antihypoxic agents; myocardial necrosis and arrhythmia, strokes, autoimmune deseases, neurodegenerative disorders |
| 09/15/2005 | US20050202449 Methods for detecting and assaying nucleic acid sequences using temperature cycling |
| 09/15/2005 | US20050202448 using newly identified cancer therapeutic targets and biomarkers (non-cancerous); overexpression |
| 09/15/2005 | US20050202447 Array print buffers |
| 09/15/2005 | US20050202446 Detecting presence of biopolymer via adding metal to biopolymer mixture, positioning biopolymer in nanopore and ramping voltage source across nanopore to produce detectable signal |
| 09/15/2005 | US20050202444 Sequential identification of linked molecules in a polymer, such as nucleotide bases of a nucleic acid, by passing the polymer through a nanometer-scale channel formed between a pair of nanoelectrodes |
| 09/15/2005 | US20050202443 Type II restriction endonuclease and application thereof |
| 09/15/2005 | US20050202442 Novel therapeutic targets in cancer |
| 09/15/2005 | US20050202441 Methods of designing, synthesizing, and propagating reference nucleic acids |
| 09/15/2005 | US20050202440 Drug screening; nuclear receptor modulators; cocrystals |
| 09/15/2005 | US20050202439 Mammalian membrane polypeptide for use in identifying modulators for prevention and treatment of urogenital disorders; contraceptives |
| 09/15/2005 | US20050202438 Using site directed mutagenesis to generate polypeptide of preferential function; two dimensional sequence analysis |
| 09/15/2005 | US20050202437 Expression vector comprised of lactobacillus and heterologous gene sequences for use as gene therapeutic tools; enhancing expression of exogenous gene sequences |
| 09/15/2005 | US20050202436 Target-specific multiple sequencing primer pool for microbial typing and sequencing applications in DNA-sequencing technologies |
| 09/15/2005 | US20050202435 Estrogen receptor alleles that are predictive of increased susceptibility to bone fracture |
| 09/15/2005 | US20050202434 Inhibition of metallo-beta-lactamase |
| 09/15/2005 | US20050202433 Using bipartite probe to identify, analyze and/or detect preferential nucleic acids in solution; detecting single fragment length polymorphisms |
| 09/15/2005 | US20050202432 Plurality of genes differentially expressed in kidney cells after exposure to hormone; identifying agents which enhance calcium uptake in post-menopausal women; diagnosing and treating cardiovascular disorders |
| 09/15/2005 | US20050202431 Coumpound for use in diagnosis and treatment of cell proliferative disorders; gene therapy; antitumor agents |
| 09/15/2005 | US20050202429 Microcapsules with controlable permeability encapsulating a nucleic acid amplification reaction mixture and their use as reaction compartment for parallels reactions |
| 09/15/2005 | US20050202427 Dipping test strip assay system and assay method for the detection and/or determination of specific uncleic acid sequences |
| 09/15/2005 | US20050202426 Whole cell engineering using real-time metabolic flux analysis |
| 09/15/2005 | US20050202424 Membrane protein for use as tool in identifying modulators for treatment of phenotype-mediated antibiotic-resistance; microbiocides; bactericides; preventing infection in cystic fibrosis patients |
| 09/15/2005 | US20050202421 Using collagen-induced arthritis (CIA) rodent model as tool in identifying differential expression patterns associated with autoimmune diseases |
| 09/15/2005 | US20050202420 Oligonucleotides or pna oligomers and a method for detecting the methylation state of genomic dna in a parallel manner |
| 09/15/2005 | US20050202419 Peroxide-driven cytochrome P450 oxygenase variants |
| 09/15/2005 | US20050202418 HCV peptide compositions |
| 09/15/2005 | US20050202417 Oligonucleotide probe for determining concentration of viral genomes in biological fluids |
| 09/15/2005 | US20050202416 Gene-specific polynucleotide primers for identifying coronavirus particles in biological fluids |
| 09/15/2005 | US20050202414 Multiplex polymerase chain reaction systems for identifying microbes and pathogenic microorganisms |
| 09/15/2005 | US20050202413 nucleic acid encoding an immunoreactive peptide not recognized by antibodies which are directed against other herpes-viruses for accurate diagnosis; test kits |
| 09/15/2005 | US20050202409 Using amino acid sequence of polypeptide to determine heat resistant characteristics; protein folding |
| 09/15/2005 | US20050202408 Chemical screening using a proline-rich nuclear receptor co-regulatory protein/nuclear receptor co-expression system |
| 09/15/2005 | US20050202407 Using variation in uptake of labeled steroids as diagnostic indicator antitumor agents |
| 09/15/2005 | US20050202406 Method for high-throughput screening of compounds and combinations of compounds for discovery and quantification of actions, particularly unanticipated therapeutic or toxic actions, in biological systems |
| 09/15/2005 | US20050202405 Methods, compositions, and kits for protein crystallization |
| 09/15/2005 | US20050202404 Using nuclear images and plasma contraction as tool in characterizing cell populations |
| 09/15/2005 | US20050202401 Characterizing genes of triplo-lethal region (Tpl) which are essential to insect propagation; biological pest control; insecticides |
| 09/15/2005 | US20050202399 Method of assay by oxidation-reduction reaction with formazan |
| 09/15/2005 | US20050202396 Microarray with increased flexibility for use in gene expression analysis |
| 09/15/2005 | US20050202077 Targeted delivery of RNA interference molecules |
| 09/15/2005 | US20050202048 Chlamydia antigens and vaccine uses of the protein |
| 09/15/2005 | US20050202043 Multimerised HIV fusion inhibitors |
| 09/15/2005 | US20050202019 Therapeutic and diagnostic applications based on the role of the CXCR-4 gene in tumorigenesis |
| 09/15/2005 | US20050202016 Polypeptide; an amino acid sequence of the family of tumour-suppressing genes related to the gene for the p53 protein; isolated nucleic acid sequences coding for the proteins |
| 09/15/2005 | US20050202013 Novel Th2-specific molecules and uses thereof |
| 09/15/2005 | US20050202008 Promotion or inhibition of angiogenesis and cardiovascularization by tumor necrosis factor ligand/receptor homologs |
| 09/15/2005 | US20050202002 Reagent; polyclonal or monoclonal antibody against the protease or its proenzyme which activates blood clotting factor VII, is inhibited by the presence of aprotinin, is increased in its activity by calcium ions, heparin, or heparin related substance |
| 09/15/2005 | US20050201999 Compounds and methods for identifying compounds which inhibit a new class of aspartyl proteases |
| 09/15/2005 | US20050201983 Capsid and capsid-expressing genome modified to display heterologous peptide(s) to allow nuclear or subcellular targeting by delivering a peptide into the cell nucleus; easy construction of libraries using site-specific recombination in vitro; peptide/protein fusion with capsid protein vp39 (AcMNPV) |
| 09/15/2005 | US20050201975 Modifying chemokine G-protein mediated signalling and/or signal transduction by administering a modulator of the Notch signalling pathway; using a fusion protein of a segment of a Notch ligand extracellular domain and an immunoglobulin Fc segment or a polynucleotide encoding it; antiinflammatory agents |
| 09/15/2005 | US20050201973 Therapeutic supramolecules |
| 09/15/2005 | US20050201937 Creation of a gradient of isotope enrichment; ability to measure a multiplicity of isotope enrichments simultaneously |
| 09/15/2005 | US20050201936 Adenoviral gene therapy; examination of the ability of various replicative, non-replicative and conditionally-replicative adenovirus vectors to treat cancer |
| 09/15/2005 | US20050201931 LAT1 transporters expressed in blood brain barrier cells |
| 09/15/2005 | US20050199917 Sensitivity enhanced biomolecule field effect transistor |
| 09/15/2005 | DE10347399B4 Bisulfit-Umwandlung zum Nachweis von Cytosin-Methylierungen in DNA mittels optimierter Aufreinigung Bisulfite conversion for the detection of cytosine methylations in DNA by means of optimized purification |
| 09/15/2005 | DE102004025269A1 Biochip cell, useful for performing rapid DNA assays, e.g. for assessing response to treatment, comprises a chip substrate, with analytical islands on its surface, and a sealed cover |
| 09/15/2005 | CA2600108A1 Granulocyte subtype-selective receptors and ion channels and uses thereof |
| 09/15/2005 | CA2559091A1 Detection of preterm labour |
| 09/15/2005 | CA2558960A1 Lactobacillus acidophilus nucleic acid sequences encoding carbohydrate utilization-related proteins and uses therefor |
| 09/15/2005 | CA2558753A1 Polymorphisms in the epidermal growth factor receptor gene promoter |
| 09/15/2005 | CA2558510A1 Thrombomodulin (thbd) haplotypes predict outcome of patients |
| 09/15/2005 | CA2557819A1 Magnetic device for isolation of cells and biomolecules in a microfluidic environment |
| 09/15/2005 | CA2557818A1 Photocleavable fluorescent nucleotides for dna sequencing on chip constructed by site-specific coupling chemistry |
| 09/15/2005 | CA2557790A1 Estimation of clinical cut-offs |
| 09/15/2005 | CA2557761A1 Method of detecting carcinogenesis caused by hepatitis b virus |
| 09/15/2005 | CA2557661A1 Nucleic acid complexes |
| 09/15/2005 | CA2557571A1 Toll-like receptor 2 (tlr-2) haplotypes predict outcome of patients |
| 09/15/2005 | CA2557568A1 Pharmacodynamic assays using flow cytometry |
| 09/15/2005 | CA2557563A1 Particle on membrane assay system |
| 09/15/2005 | CA2557304A1 Ketoamides with cyclic p4's as inhibitors of ns3 serine protease of hepatitis c virus |
| 09/15/2005 | CA2555912A1 Functional materials and novel methods for the fabrication of microfluidic devices |
| 09/15/2005 | CA2555656A1 New proliferation markers in clinical practice and their use for cancer prognosis or diagnosis |
| 09/15/2005 | CA2554966A1 Methods and compostions for targeted cleavage and recombination |
| 09/14/2005 | EP1574858A1 Analyte test system for determining the concentration of an analyte in a physiological or aqueous fluid |
| 09/14/2005 | EP1574848A1 Biosensor |
| 09/14/2005 | EP1574837A1 Method and apparatus for sequencing polymers through tunneling conductance variation detection |